Despite claims of a decisive response to Covid-19, evidence suggests that whistleblowers faced severe repercussions, ...
"After more than 10 years of in-depth cooperation, Yili's industrial footprint in New Zealand now spans the entire industry chain, including milk source partnerships, innovation and R&D, production ...
BEIJING -- China's pediatric and adolescent cancer patients have achieved a 5-year survival rate of 77.2 percent, marking ...
A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia ...
More than 80 per cent of genomic studies across the world looking into diseases are concentrated in high-income countries, ...
With nearly half of Chinese adults classified as overweight or obese, the policy represents the first time a city has enacted ...
The Chinese government once focused on political dissidents and exiled activists. Now, federal officials say, it is targeting ...
The Nation UAE on MSN
CG OIC-COMSTECH underscores traditional medicine as sustainable solution to global health challenges
At a time when rising healthcare costs, drug insecurity and unequal access to treatment are straining health systems worldwide, ...
Traveling to different countries requires you to make sure you're aware of different rules they have in place, and among ...
She was given the “hardest job under heaven”: upholding birth limits enforced by often brutal local officials. She came to support softening the policy, then abolishing it.
AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
The AUSHINE study is a randomized, double-blind, multicenter Phase III trial evaluating the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with nucleos (t)ide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results